全文获取类型
收费全文 | 688篇 |
免费 | 41篇 |
国内免费 | 1篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 9篇 |
妇产科学 | 35篇 |
基础医学 | 69篇 |
口腔科学 | 12篇 |
临床医学 | 55篇 |
内科学 | 140篇 |
皮肤病学 | 20篇 |
神经病学 | 36篇 |
特种医学 | 6篇 |
外科学 | 129篇 |
综合类 | 8篇 |
一般理论 | 1篇 |
预防医学 | 63篇 |
眼科学 | 9篇 |
药学 | 69篇 |
中国医学 | 1篇 |
肿瘤学 | 67篇 |
出版年
2023年 | 6篇 |
2022年 | 19篇 |
2021年 | 26篇 |
2020年 | 23篇 |
2019年 | 24篇 |
2018年 | 20篇 |
2017年 | 18篇 |
2016年 | 18篇 |
2015年 | 18篇 |
2014年 | 23篇 |
2013年 | 28篇 |
2012年 | 48篇 |
2011年 | 46篇 |
2010年 | 20篇 |
2009年 | 25篇 |
2008年 | 35篇 |
2007年 | 31篇 |
2006年 | 33篇 |
2005年 | 29篇 |
2004年 | 30篇 |
2003年 | 29篇 |
2002年 | 26篇 |
2001年 | 19篇 |
2000年 | 12篇 |
1999年 | 20篇 |
1995年 | 6篇 |
1994年 | 2篇 |
1993年 | 2篇 |
1992年 | 4篇 |
1991年 | 3篇 |
1990年 | 3篇 |
1989年 | 2篇 |
1988年 | 5篇 |
1987年 | 8篇 |
1986年 | 6篇 |
1985年 | 6篇 |
1984年 | 6篇 |
1983年 | 4篇 |
1979年 | 4篇 |
1978年 | 2篇 |
1977年 | 2篇 |
1976年 | 3篇 |
1975年 | 4篇 |
1974年 | 6篇 |
1973年 | 2篇 |
1972年 | 7篇 |
1971年 | 5篇 |
1970年 | 2篇 |
1969年 | 2篇 |
1968年 | 2篇 |
排序方式: 共有730条查询结果,搜索用时 15 毫秒
61.
62.
Ana Kalušević Steva Lević Bojan Čalija Milena Pantić Miona Belović Vladimir Pavlović 《Journal of microencapsulation》2017,34(5):475-487
Black soybean coat is insufficiently valorised food production waste rich in anthocyanins. The goal of the study was to examine physicochemical properties of spray dried extract of black soybean coat in regard to carrier materials: maltodextrin, gum Arabic, and skimmed milk powder. Maltodextrin and gum Arabic-based microparticles were spherical and non-porous while skimmed milk powder-based were irregularly shaped. Low water activity of microparticles (0.31–0.33), good powders characteristics, high solubility (80.3–94.3%) and encapsulation yields (63.7–77.0%) were determined. All microparticles exhibited significant antioxidant capacity (243–386 μmolTE/g), good colour stability after three months of storage and antimicrobial activity. High content of total anthocyanins, with cyanidin-3-glucoside as predominant, were achieved. In vitro release of anthocyanins from microparticles was sustained, particularly from gum Arabic-based. These findings suggest that proposed simple eco-friendly extraction and microencapsulation procedures could serve as valuable tools for valorisation and conversion of black soybean coat into highly functional and stable food colourant. 相似文献
63.
We report the rare finding of a complete cleft of the secondary palate in the presence of a synechial band running from the incisive foramen over the tip of the tongue, terminating in the midline of the floor of the mouth. 相似文献
64.
Ye H Oo Tracey Dudley Peter Nightingale Geoffrey Haydon David Mutimer 《Liver transplantation》2008,14(1):81-87
Hepatitis C virus (HCV)-induced cirrhosis is the most common indication for liver transplantation (LT). However, graft reinfection is nearly universal. The choice of immunosuppression, including the calcineurin inhibitor (CNI), may have some effect on severity of recurrence and graft survival. In addition, HCV recurrence may have some impact on metabolism of immunosuppressive drugs. In this retrospective study, we examined the dose and blood levels of tacrolimus (TAC) and cyclosporin A (CYA) in HCV patients consecutively undergoing transplantation (TAC, n = 44; CYA, n = 60) and surviving 12 months post-LT. In addition, we examined the CNI dose and blood levels in an age- and gender-matched comparison group of patients who were transplanted for alcoholic liver disease (ALD) (TAC, n = 44; CYA, n = 47). During the 12-month period of observation, TAC levels were significantly higher for HCV than for ALD patients (P = 0.002). The dose of TAC decreased over time for both HCV and ALD patients (P < 0.001), but the reduction was greater for HCV patients (P = 0.03). CYA dose decreased over time for both groups (P < 0.001) but a greater reduction was observed for the HCV group (P = 0.007). For both HCV and ALD patients, CYA levels decreased over time (P < 0.001) but there was no significant difference between HCV and ALD patients. Thus, to maintain comparable blood levels, a greater reduction of dose was required for HCV than for ALD patients. In conclusion, our observations demonstrate a likely effect of HCV infection on CNI metabolism, an effect that is not clearly due to graft damage. Physicians need to be alert to this interaction and to the need to respond quickly to changes in CNI levels that may be associated with HCV infection and with HCV clearance during antiviral therapy. 相似文献
65.
66.
Bawm Saw Kakisaka Keita Thu May June Chel Hla Myet Oo Yamon Min Nyunt Soe Nyein Chan Win Shwe Yee Htun Lat Lat Win Mar Mar Suzuki Hitoshi Nakao Ryo Katakura Ken 《Parasitology research》2018,117(10):3361-3364
Parasitology Research - Tick-borne intracellular protozoan parasites of the Theileria genus infect a wide range of both domestic and wild animals. In the present study, we describe the first PCR... 相似文献
67.
68.
Kilby JM Sfakianos G Gizzi N Siemon-Hryczyk P Ehrensing E Oo C Buss N Saag MS 《Antimicrobial agents and chemotherapy》2000,44(10):2672-2678
Human immunodeficiency virus type 1 (HIV-1) protease inhibitors have dramatically improved treatment options for HIV infection, but frequent dosing may impact adherence to highly active antiretroviral treatment regimens (HAART). Previous studies demonstrated that combined therapy with ritonavir and saquinavir allows a decrease in frequency of saquinavir dosing to twice daily. In this study, we evaluated the safety and pharmacokinetics of combining once-daily doses of the soft-gel capsule (SGC) formulation of saquinavir (saquinavir-SGC) and minidose ritonavir. Forty-four healthy HIV-negative volunteers were randomized into groups receiving once-daily doses of saquinavir-SGC (1,200 to 1,800 mg) plus ritonavir (100 to 200 mg) or a control group receiving only saquinavir-SGC (1,200 mg) three times daily. Saquinavir-SGC alone and saquinavir-SGC-ritonavir combinations were generally well tolerated, and there were no safety concerns. Addition of ritonavir (100 mg) to saquinavir-SGC (1,200 to 1,800 mg/day) increased the area under the concentration-time curve (AUC) for saquinavir severalfold, and the intersubject peak concentration in plasma and AUC variability were reduced compared to those achieved with saquinavir-SGC alone (3,600 mg/day), while trough saquinavir levels (24 h post-dose) were substantially higher than the 90% inhibitory concentration calculated from HIV-1 clinical isolates. Neither increasing the saquinavir-SGC dose to higher than 1,600 mg nor increasing ritonavir from 100 to 200 mg appeared to further enhance the AUC. These results suggest that an all once-daily HAART regimen, utilizing saquinavir-SGC plus a more tolerable low dose of ritonavir, may be feasible. Studies of once-daily saquinavir-SGC (1,600 mg) in combination with ritonavir (100 mg) in HIV-infected patients are underway. 相似文献
69.
Successful liver allografts in mice by combination with allogeneic bone marrow transplantation. 总被引:1,自引:2,他引:1 下载免费PDF全文
T Nakamura R A Good R Yasumizu S Inoue M M Oo Y Hamashima S Ikehara 《Proceedings of the National Academy of Sciences of the United States of America》1986,83(12):4529-4532
Successful liver allografts were established by combination with allogeneic bone marrow transplantation. When liver tissue of BALB/c (H-2d) or C57BL/6J (H-2b) mice was minced and grafted under the kidney capsules of C3H/HeN (H-2k) mice, it was rejected. However, when C3H/HeN mice were irradiated and reconstituted with T-cell-depleted BALB/c or BALB/c nu/nu bone marrow cells, or with fetal liver cells of BALB/c mice, they accepted both donor (stem-cell)-type (BALB/c) and host (thymus)-type (C3H/HeN) liver tissue. Assays for both mixed-lymphocyte reaction and induction of cytotoxic T lymphocytes revealed that the newly developed T cells were tolerant of both donor (stem-cell)-type and host (thymus)-type major histocompatibility complex determinants. We propose that liver allografts combined with bone marrow transplantation should be considered as a viable therapy for patients with liver disease such as liver cirrhosis and hepatoma. 相似文献
70.